COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,610 Articles (22,913 medRxiv, 8,697 bioRxiv)

Most recent first Previous |  Page 1152: Articles 11511-11520  | Next

SARS-CoV-2 genome-based severity predictions correspond to lower qPCR values and higher viral load
Skarzynski, M., McAuley, E. M., Maier, E. J., Fries, A. C., Voss, J. D., Chapleau, R. R.
10.1101/2021.11.22.21266688 — Posted: 2021-11-24
Sustained negative mental health outcomes among healthcare workers over the first year of the COVID-19 pandemic: a prospective cohort study
Mediavilla, R., Fernandez-Jimenez, E., Martinez-Morata, I., Jaramillo, F., Andreo-Jover, J., Moran-Sanchez, I., Mascayano, F., Moreno-Kustner, B., Minue, S., Ayuso-Mateos, J. L., Bryant, R. A., Bravo-Ortiz, M.-F., Martinez-Ales, G., COVID-19 HEalth caRe wOrkErS Spain (HEROES-SPA) Group
10.1101/2021.11.21.21266594 — Posted: 2021-11-24
Behaviour, booster vaccines and waning vaccine protection: modelling the medium-term dynamics of SARS-CoV-2 transmission in England
Barnard, R. C., Davies, N. G., Centre for Mathematical Modelling of Infectious Diseases COVID-19 working group, , Jit, M., Edmunds, J.
10.1101/2021.11.22.21266584 — Posted: 2021-11-24
Social Class, Race/Ethnicity, and COVID-19 Mortality Among Working Age Adults in the United States
Pathak, E. B., Menard, J. M., Garcia, R. B., Salemi, J. L.
10.1101/2021.11.23.21266759 — Posted: 2021-11-24
A comparison of health care use after severe COVID-19, respiratory syncytial virus, and influenza in children
Larsen, V. B., Stordal, K., Telle, K., Methi, F., Magnusson, K.
10.1101/2021.11.22.21266522 — Posted: 2021-11-24
Efficacy and safety of a novel antiviral preparation in ICU-admitted patients with COVID-19: a phase III randomized controlled trial
Faramarzi, H., Sahebkar, A., Hosseinpour, A., Khaloo, V., Chamanpara, P., Heydari, M. R., Najafi, S., Fotoohi Khankahdany, F., Movahedpour, A.
10.1101/2021.11.20.21266229 — Posted: 2021-11-23
COVID-19 vaccination and menstrual cycle changes: A United Kingdom (UK) retrospective case-control study
Alvergne, A., Kountourides, G., Argentieri, A., Agyen, L., Rogers, N., Knight, D., Sharp, G. C., Maybin, J. A., Olszewska, Z.
10.1101/2021.11.23.21266709 — Posted: 2021-11-23 Discussion: Onsite
Conserved recombination patterns across coronavirus subgenera
de Klerk, A., Swanepoel, P. I., Lourens, R. F., Zondo, M., Abodunran, I., Lytras, S., MacLean, O., Robertson, D. L., Kosakovsky Pond, S. L., Zehr, J. D., Kumar, V., Stanhope, M. J., Harkins, G., Murrell, B., Martin, D.
10.1101/2021.11.21.469423 — Posted: 2021-11-23
Identification of a promiscuous conserved CTL epitope within the SARS-CoV-2 spike protein
Jiang, S., Wu, S., Zhao, G., He, Y., Guo, X., Zhang, Z., Hou, J., Ding, Y., Cheng, A., Wang, B.
10.1101/2021.11.21.469172 — Posted: 2021-11-23
Preclinical efficacy, safety, and immunogenicity of PHH-1V, a second-generation COVID-19 vaccine candidate based on a novel recombinant RBD fusion heterodimer of SARS-CoV-2.
Barreiro, A., Prenafeta, A., Bech-Sabat, G., Roca, M., March, R., Gonzalez, L., Madrenas, L., Corominas, J., Fernandez, A., Molas, M., Vergara-Alert, J., Lorca-Oro, C., Roca, N., Fernandez-Bastit, L., Rodon, J., Perez, M., Segales, J., Pradenas, E., Marfil, S., Trinite, B., Ortiz, R., Clotet, B., Blanco, J., Diaz Pedroza, J., Ampudia Carrasco, R., Rosales Salgado, Y., Loubat Casanovas, J., Capdevila Larripa, S., Garcia Prado, J., Barretina Ginesta, J., Sistere-Oro, M., Cebollada Rica, P., Meyerhans, A., Ferrer, L., Torroella, E.
10.1101/2021.11.22.469117 — Posted: 2021-11-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).